2,962
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Long-term stability in obsessive thoughts and compulsive behavior in the general population: a longitudinal study in Sweden

, , , , ORCID Icon &
Pages 574-580 | Received 03 Sep 2022, Accepted 11 Mar 2023, Published online: 08 Apr 2023

References

  • APA. Diagnostic and statistical manual of mental disorders, fifth edition, DSM-5. Washington, D.C.: American Psychiatric Publishing; 2013.
  • WHO. The ICD-10 classification of mental and behavioural disorders. Clinical descriptions and diagnostic guidelines. Genève, Switzerland: World Health Organization. 1993. p. 1–362.
  • Angst J, Gamma A, Endrass J, et al. Obsessive-compulsive syndromes and disorders. Eur Arch Psychiatry Clin Neurosci. 2005;255(1):65–71.
  • Adam Y, Meinlschmidt G, Gloster AT, et al. Obsessive-compulsive disorder in the community: 12-month prevalence, comorbidity and impairment. Soc Psychiatry Psychiatr Epidemiol. 2012;47(3):339–349.
  • Fineberg NA, Hengartner MP, Bergbaum CE, et al. A prospective population-based cohort study of the prevalence, incidence and impact of obsessive-compulsive symptomatology. Int J Psychiatry Clin Pract.2013;17(3):170–178.
  • Ruscio AM, Stein DJ, Chiu WT, et al. The epidemiology of obsessive-compulsive disorder in the national comorbidity survey replication. Mol Psychiatry. 2010;15(1):53–63.
  • Hirschtritt ME, Bloch MH, Mathews CA. Obsessive-compulsive disorder: advances in diagnosis and treatment. JAMA. 2017;317(13):1358–1367.
  • Skoog G, Skoog I. A 40-year follow-up of patients with obsessive-compulsive disorder. Archives of general psychiatry. Arch Gen Psychiatry. 1999;56(2):121–127.
  • Bloch MH, Green C, Kichuk SA, et al. Long-term outcome in adults with obsessive-compulsive disorder. Depress Anxiety. 2013;30(8):716–722. Aug
  • Sharma E, Thennarasu K, Reddy YC. Long-term outcome of obsessive-compulsive disorder in adults: a meta-analysis. J Clin Psychiatry. 2014;75(9):1019–1027.
  • Läkemedelsverket. Läkemedelsbehandling av depression, ångestsyndrom och tvångssyndrom hos barn och vuxna. Vol. 6. 2016. Information från Läkemedelsverket [Information from the Swedish Medical Products Agency]
  • SBU. Behandling av ångestsyndrom - En systematisk litteraturöversikt. Vol. September 2005 2005.
  • NICE. Obsessive compulsive disorder: core interventions in the treatment of obsessive compulsive disorder and body dysmorphic disorder. National Collaborating Centre for Mental Health Commissioned by National Institute for Health and Clinical Excellence. 2006;31:1–350.
  • Koran LM, Simpson BH. Guideline Watch (March 2013): practice guideline for the treatment of patients with obsessive-compulsive disorder2013. APA Practice Guidelines Legacy Collection.
  • Bandelow B, Zohar J, Hollander E, et al. World federation of societies of biological psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision. World J Biol Psychiatry. 2008;9(4):248–312.
  • Hällström T, Thakker KD, Forsell Y, et al. The PART Study. A Population Based Study of Mental Health in the Stockholm County: study Design. Phase l (1998–2000)2003.
  • Lundberg I, Damström Thakker K, Hällström T, et al. Determinants of non-participation, and the effects of non-participation on potential cause-effect relationships, in the PART study on mental disorders. Soc Psychiatry Psychiatr Epidemiol. 2005;40(6):475–483.
  • Wettermark B, Hammar N, Fored CM, et al. The new Swedish prescribed drug register—opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf. 2007;16(7):726–735.
  • Wing JK, Babor T, Brugha T, et al. Scan - schedules for clinical-assessment in neuropsychiatry. Arch GenPsychiatry. 1990;47(6):589–593.
  • Spri Ångestsyndrom - kliniska riktlinjer för utredning och behandling [The swedish psychiatric association clinical guidelines for assessment and treatment on anxiety syndromes]. The Swedish Psychiatric Association. Spris förlag. 1997; 1–69
  • Shekelle PG, Woolf SH, Eccles M, et al. Developing clinical guidelines. West J Med. 1999;170(6):348–351.
  • Marks IM, Mathews AM. Brief standard self-rating for phobic patients. Behav Res Ther. 1979;17(3):263–267. [pii]
  • Sheehan D. The anxiety disease. New York: Charles Scribners Sons; 1983. 124–129.
  • Derogatis LR, Lipman RS, Rickels K, et al. The hopkins symptom checklist (HSCL): a self-report symptom inventory. Behav Sci. 1974;19(1):1–15.
  • Olsen LR, Jensen DV, Noerholm V, et al. The internal and external validity of the major depression inventory in measuring severity of depressive states. Psychol Med. 2003;33(2):351–356.
  • Hosmer DW, Lemeshow S, eds. Applied logistic regression. 2nd ed. New York: John Wiley & Sons, Inc.; 2000.
  • Bijl RV, Ravelli A, van Zessen G. Prevalence of psychiatric disorder in the general population: results of The Netherlands mental health survey and incidence study (NEMESIS). Soc Psychiatry Psychiatr Epidemiol. 1998;33(12):587–595.
  • Fullana MA, Vilagut G, Rojas-Farreras S, et al. Obsessive–compulsive symptom dimensions in the general population: results from an epidemiological study in six european countries. J Affect Disord. 2010;124(3):291–299.
  • Fontenelle LF, Mendlowicz MV, Versiani M. The descriptive epidemiology of obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry.2006;30(3):327–337.
  • Bebbington PE. Epidemiology of obsessive-compulsive disorder. Br J Psychiatry. 1998;Suppl.(35):2–6.
  • Angst J, Gamma A, Endrass J, et al. Obsessive-compulsive severity spectrum in the community: prevalence, comorbidity, and course. Eur Arch Psychiatry Clin Neurosci. 2004;254(3):156–164.
  • Sharma E, Thennarasu K, Reddy YJ. Long-term outcome of obsessive-compulsive disorder in adults: a meta-analysis. J Clin Psychiatry. 2014;75(9):10746.
  • Torres AR, Prince MJ, Bebbington PE, et al. Treatment seeking by individuals with obsessive-compulsive disorder from the British psychiatric morbidity survey of 2000. Psychiatr Serv. 2007;58(7):977–982.
  • Eisen JL, Goodman WK, Keller MB, et al. Patterns of remission and relapse in obsessive-compulsive disorder: a 2-year prospective study. J Clin Psychiat. May 1999;60(5):346–351. quiz 352.
  • Mataix-Cols D, Rauch SL, Baer L, et al. Symptom stability in adult obsessive-compulsive disorder: data from a naturalistic two-year follow-up study. Am J Psychiatry. 2002;159(2):263–268.
  • Joseph KS, Mehrabadi A, Lisonkova S. Confounding by indication and related concepts. Curr Epidemiol Rep. 2014;1(1):1–8.
  • Socialstyrelsen. Vård vid depression och ångestsyndrom – Stöd för styrning och ledning Stöd för styrning och ledning [Care for depression and anxiety syndrome - Support for guidance and government]. Vol. [https://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/20743/2017-12-4.pdf. ]. 2017. Nationella Riktlinjer [National Guidelines].
  • Wittchen HU, Lieb R, Pfister H, et al. The waxing and waning of mental disorders: evaluating the stability of syndromes of mental disorders in the population. Compr Psychiatry. 2000;41(2 Suppl 1):122–132.
  • Attiullah N, Eisen JL, Rasmussen SA. Clinical features of obessive-compulive disorder. Psychiatr Clin N. Am. 2000/09/01/2000;23(3):469–491.
  • Mataix-Cols D. Deconstructing obsessive-compulsive disorder: a multidimensional perspective. Curr Opin Psychiatry. 2006;19(1):84–89.
  • Guzick AG, Candelari A, Wiese AD, et al. Obsessive–compulsive disorder during the COVID-19 pandemic: a systematic review. Curr Psychiatry Rep. 2021;23:1–10.